EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 59.80K | 382.00K | -1.43M | -1.28M | -730.80K |
| Total Depreciation and Amortization | 83.70K | 88.30K | 90.70K | 93.10K | 96.80K |
| Total Amortization of Deferred Charges | 42.80K | 41.70K | 38.90K | 34.80K | 29.90K |
| Total Other Non-Cash Items | -1.62M | -1.95M | -26.30K | 31.40K | -74.00K |
| Change in Net Operating Assets | 1.11M | 1.16M | 886.80K | 574.00K | 341.70K |
| Cash from Operations | -325.00K | -273.40K | -438.30K | -544.70K | -336.50K |
| Capital Expenditure | -59.20K | -66.70K | -66.70K | -7.50K | -8.40K |
| Sale of Property, Plant, and Equipment | 24.80K | 24.80K | 24.80K | 24.80K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -4.35M | -4.35M | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 96.40K |
| Cash from Investing | -4.38M | -4.39M | -41.90K | 17.30K | 88.00K |
| Total Debt Issued | 27.70K | 87.70K | 363.10K | 435.00K | -1.26M |
| Total Debt Repaid | -40.00K | -60.00K | -100.00K | -100.00K | 1.48M |
| Issuance of Common Stock | -- | -- | -- | -- | 99.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.87M | 5.87M | 1.28M | 1.28M | -12.70K |
| Cash from Financing | 4.65M | 4.68M | 1.25M | 1.30M | 238.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.40K | 20.50K | 766.90K | 774.80K | -9.90K |
